0001839882-23-012503.txt : 20230510
0001839882-23-012503.hdr.sgml : 20230510
20230510171349
ACCESSION NUMBER: 0001839882-23-012503
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230508
FILED AS OF DATE: 20230510
DATE AS OF CHANGE: 20230510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRANGE DAVID L
CENTRAL INDEX KEY: 0001264908
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36019
FILM NUMBER: 23907653
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp.
CENTRAL INDEX KEY: 0001430306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261434750
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 MAIN STREET, SUITE 101
CITY: CHATHAM
STATE: NJ
ZIP: 07928
BUSINESS PHONE: 212-980-9155
MAIL ADDRESS:
STREET 1: 26 MAIN STREET, SUITE 101
CITY: CHATHAM
STATE: NJ
ZIP: 07928
FORMER COMPANY:
FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC.
DATE OF NAME CHANGE: 20080320
4
1
ownership.xml
X0407
4
2023-05-08
0
0001430306
Tonix Pharmaceuticals Holding Corp.
TNXP
0001264908
GRANGE DAVID L
C/O TONIX PHARMACEUTICALS HOLDING CORP.
26 MAIN STREET, SUITE 101
CHATHAM
NJ
07928
1
0
0
0
0
Stock Option
0.509
2023-05-08
4
A
0
60000
0.00
A
2024-05-08
2033-05-08
Common Stock
60000
60000
D
The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan and vests on the earlier of the one year anniversary of the grant date or the Issuer's 2024 Annual Meeting of Stockholders.
Does not reflect a 1-for-6.25 reverse stock split of the Issuer's common stock effective May 10, 2023.
/s/ Jessica Morris, Attorney-in-Fact
2023-05-10